申请人:Medicinal Bioconvergence Research Center
公开号:EP3786163A1
公开(公告)日:2021-03-03
The present invention relates to a novel compound as an mTOR inhibitor and a use thereof and, more specifically, to a novel compound represented by formula 1 that exhibits mTOR inhibitory activity and a pharmaceutical composition comprising same as an active ingredient for preventing or treating brain diseases associated with an mTOR pathway.
本发明涉及一种作为mTOR抑制剂的新化合物及其用途,更具体地,涉及一种由式1表示的新化合物,该化合物表现出mTOR抑制活性,并且包括该化合物作为活性成分的药物组合物,用于预防或治疗与mTOR途径相关的脑疾病。